Repligen (RGEN) Free Cash Flow Growth (5y) (2015 - 2026)
Repligen (RGEN) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33% |
| Mar 31, 2026 | 69.66% |
| Dec 31, 2025 | 38.19% |
| Sep 30, 2025 | 19.63% |
| Jun 30, 2025 | 9.65% |
| Mar 31, 2025 | 16.19% |
| Dec 31, 2024 | 26.02% |
| Sep 30, 2024 | 20.89% |
| Jun 30, 2024 | 21.65% |
| Mar 31, 2024 | 36.41% |
| Dec 31, 2023 | 51.03% |
| Sep 30, 2023 | 13.02% |
| Jun 30, 2023 | 53.13% |
| Mar 31, 2023 | 219.06% |
| Dec 31, 2022 | 25.24% |
| Sep 30, 2022 | 66.49% |
| Jun 30, 2022 | 70.00% |
| Mar 31, 2022 | -94.23% |
| Dec 31, 2021 | 74.20% |
| Sep 30, 2021 | 41.01% |